| 0.8 |
5.0 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
1.8 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.6 |
2.8 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.6 |
2.2 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.5 |
1.5 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.5 |
1.5 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.5 |
1.9 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.5 |
0.9 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.4 |
1.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.4 |
1.2 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.4 |
1.1 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.4 |
1.5 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
1.0 |
GO:0048818 |
embryonic nail plate morphogenesis(GO:0035880) positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) frontal suture morphogenesis(GO:0060364) |
| 0.3 |
1.0 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 |
1.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.3 |
1.0 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.3 |
1.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.3 |
1.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.3 |
0.6 |
GO:0042637 |
catagen(GO:0042637) |
| 0.3 |
0.6 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.3 |
1.2 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.3 |
1.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.3 |
0.6 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.3 |
1.2 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.3 |
1.7 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.3 |
0.9 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.3 |
1.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 |
0.8 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) positive regulation of transforming growth factor beta3 production(GO:0032916) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.3 |
1.4 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.3 |
0.8 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.3 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.3 |
0.3 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.3 |
0.8 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.3 |
1.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.3 |
1.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 |
0.8 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.3 |
1.3 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.3 |
0.3 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.3 |
0.8 |
GO:0090403 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of fermentation(GO:0043465) oxidative stress-induced premature senescence(GO:0090403) negative regulation of fermentation(GO:1901003) |
| 0.3 |
1.0 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.3 |
1.0 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.2 |
1.0 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
1.2 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 |
0.7 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.2 |
0.7 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
0.7 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 |
1.9 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.2 |
0.2 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.2 |
1.2 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.2 |
0.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.2 |
0.2 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.2 |
2.1 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.2 |
0.9 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.2 |
0.4 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.2 |
1.5 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.2 |
1.9 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 |
0.6 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.2 |
0.8 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.2 |
1.0 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 |
0.6 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.2 |
0.6 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.2 |
1.4 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 0.2 |
0.6 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.2 |
1.3 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
0.7 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 |
2.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 |
0.2 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 |
0.5 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
1.3 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 |
0.7 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 |
0.5 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.2 |
0.9 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.2 |
1.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
0.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
0.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.2 |
0.5 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.2 |
0.7 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
1.7 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.2 |
0.5 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.2 |
0.8 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 |
0.5 |
GO:1900864 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.2 |
1.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
1.0 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 |
0.8 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
0.5 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.2 |
1.5 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.2 |
1.0 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.2 |
0.5 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.2 |
1.4 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
0.5 |
GO:0010950 |
positive regulation of endopeptidase activity(GO:0010950) |
| 0.2 |
0.5 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.2 |
0.5 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.2 |
0.9 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.4 |
GO:0046032 |
ADP catabolic process(GO:0046032) |
| 0.1 |
1.5 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.7 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.1 |
0.4 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.4 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
1.0 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.1 |
0.8 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 |
0.8 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.1 |
1.0 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.4 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.1 |
0.4 |
GO:1902445 |
negative regulation of oxidative phosphorylation(GO:0090324) regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.6 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 |
0.4 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.4 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.1 |
0.5 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.4 |
GO:0045014 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.1 |
1.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.4 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.5 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.3 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 |
0.4 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.8 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
0.6 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.1 |
0.5 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.1 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 0.1 |
0.4 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.1 |
0.5 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 |
0.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 |
0.7 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
1.2 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.1 |
1.0 |
GO:0055064 |
carbon dioxide transport(GO:0015670) chloride ion homeostasis(GO:0055064) |
| 0.1 |
1.9 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.1 |
1.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.4 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
1.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.6 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.5 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.1 |
0.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.3 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.1 |
1.2 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
0.5 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 |
2.0 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.1 |
0.8 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.9 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) positive regulation of centrosome cycle(GO:0046607) |
| 0.1 |
1.1 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.3 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.1 |
0.4 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.9 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
1.0 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.2 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.1 |
0.4 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.3 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 |
0.6 |
GO:0042795 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.2 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 0.1 |
0.4 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
3.2 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.1 |
3.1 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.1 |
0.6 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.8 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.6 |
GO:0034397 |
telomere localization(GO:0034397) |
| 0.1 |
0.9 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.6 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
0.5 |
GO:0021905 |
pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) |
| 0.1 |
0.1 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.1 |
0.4 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.1 |
0.3 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 |
0.9 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.1 |
0.5 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.5 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
0.3 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 0.1 |
0.3 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.1 |
0.2 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.1 |
0.2 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.1 |
0.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.3 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.4 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.1 |
0.2 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
0.4 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 |
0.3 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.2 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.1 |
0.3 |
GO:0071594 |
T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
| 0.1 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.7 |
GO:0001839 |
neural plate morphogenesis(GO:0001839) |
| 0.1 |
0.4 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 |
0.3 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.1 |
0.3 |
GO:0009414 |
response to water deprivation(GO:0009414) response to water(GO:0009415) |
| 0.1 |
0.6 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
0.9 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.1 |
0.2 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.3 |
GO:1904816 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 |
0.2 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.3 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.3 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.4 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.9 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 0.1 |
0.5 |
GO:0007320 |
insemination(GO:0007320) |
| 0.1 |
0.2 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.5 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.1 |
0.2 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
0.6 |
GO:0043247 |
protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.1 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.7 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.5 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 |
0.1 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 |
0.9 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.1 |
0.2 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
1.1 |
GO:0051984 |
positive regulation of chromosome segregation(GO:0051984) |
| 0.1 |
0.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.1 |
0.3 |
GO:0010878 |
cholesterol storage(GO:0010878) |
| 0.1 |
0.9 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.4 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.1 |
0.1 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 |
1.4 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.7 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.1 |
0.5 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.7 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
0.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.2 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 |
0.1 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.1 |
0.5 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.9 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.3 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.1 |
0.4 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.1 |
1.4 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.2 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.1 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.1 |
0.3 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
1.8 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.1 |
0.3 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.1 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.1 |
0.4 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
2.9 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.1 |
0.5 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 |
0.2 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.1 |
0.8 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.1 |
0.2 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.1 |
1.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.1 |
0.5 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.1 |
0.7 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.1 |
0.4 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.3 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
0.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 |
0.3 |
GO:0061525 |
hindgut development(GO:0061525) |
| 0.1 |
0.3 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.4 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.3 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.3 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.1 |
0.6 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.1 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
0.3 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.2 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.1 |
1.5 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.1 |
0.1 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
0.3 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.3 |
GO:0042775 |
mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.1 |
0.1 |
GO:0061344 |
regulation of cell adhesion involved in heart morphogenesis(GO:0061344) positive regulation of ephrin receptor signaling pathway(GO:1901189) |
| 0.1 |
0.8 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.3 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 |
0.7 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.4 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.1 |
0.5 |
GO:0010992 |
bradykinin catabolic process(GO:0010815) ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.2 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.1 |
0.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
0.4 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.1 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.4 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.2 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.1 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.3 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.8 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 |
0.4 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.1 |
0.8 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.2 |
GO:2000269 |
regulation of fibroblast apoptotic process(GO:2000269) |
| 0.1 |
0.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.2 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.1 |
1.5 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.1 |
1.0 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
1.4 |
GO:0009409 |
response to cold(GO:0009409) |
| 0.1 |
0.7 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.1 |
1.1 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.7 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
0.5 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.3 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.2 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.1 |
0.4 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.5 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.1 |
0.4 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.1 |
GO:1903912 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
0.1 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
0.4 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.3 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.9 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.1 |
0.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.3 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
0.7 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.1 |
0.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
0.2 |
GO:0072488 |
transepithelial ammonium transport(GO:0070634) ammonium transmembrane transport(GO:0072488) |
| 0.1 |
0.1 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.1 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.6 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 |
0.4 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.1 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.6 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.3 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.2 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.1 |
0.3 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.6 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.4 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
0.7 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.1 |
0.5 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.1 |
0.2 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 0.1 |
1.0 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.1 |
1.3 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.3 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.0 |
0.4 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.0 |
0.1 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
| 0.0 |
0.7 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.2 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.1 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.0 |
0.3 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) |
| 0.0 |
0.5 |
GO:0071025 |
RNA surveillance(GO:0071025) |
| 0.0 |
0.2 |
GO:0019614 |
phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.0 |
0.3 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.2 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.2 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.2 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.0 |
0.1 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.0 |
0.2 |
GO:0038089 |
positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.0 |
0.2 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) |
| 0.0 |
0.3 |
GO:0097491 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
1.2 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
1.5 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.5 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.6 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
1.0 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.5 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.0 |
0.1 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.0 |
0.3 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.0 |
0.2 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.3 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.0 |
0.2 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.0 |
0.1 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.0 |
0.4 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.0 |
0.3 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.8 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.0 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.0 |
0.9 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.0 |
0.4 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.0 |
0.3 |
GO:0032691 |
negative regulation of interleukin-1 beta production(GO:0032691) |
| 0.0 |
0.4 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.0 |
0.0 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.0 |
2.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.2 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.3 |
GO:1901020 |
negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
| 0.0 |
0.8 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.6 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.0 |
0.4 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.5 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.0 |
0.1 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.0 |
1.0 |
GO:2000816 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.0 |
0.1 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.0 |
0.4 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.0 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.0 |
0.1 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.0 |
0.2 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 |
2.0 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.2 |
GO:2000648 |
positive regulation of stem cell proliferation(GO:2000648) |
| 0.0 |
0.1 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.0 |
0.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.4 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.6 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.3 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.5 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.1 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.0 |
0.4 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.1 |
GO:0048382 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) mesendoderm development(GO:0048382) |
| 0.0 |
0.5 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.0 |
0.2 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.5 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.0 |
0.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.0 |
0.3 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.4 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.4 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.6 |
GO:0042633 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.0 |
0.3 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.1 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.0 |
0.4 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.0 |
1.4 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.0 |
0.5 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.4 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0040038 |
polar body extrusion after meiotic divisions(GO:0040038) |
| 0.0 |
0.2 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 |
0.2 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.5 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.0 |
0.2 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.0 |
0.5 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.5 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.6 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.0 |
0.1 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.0 |
0.4 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.6 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.2 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.2 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.0 |
0.3 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
0.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.6 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.5 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.1 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.0 |
0.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.2 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.0 |
0.1 |
GO:2001204 |
macrophage activation involved in immune response(GO:0002281) regulation of osteoclast development(GO:2001204) |
| 0.0 |
0.4 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
1.1 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.3 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.1 |
GO:0046959 |
habituation(GO:0046959) |
| 0.0 |
0.2 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.1 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.5 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.6 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
1.4 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.1 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
0.3 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.1 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.1 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.1 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.0 |
0.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.3 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.0 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.0 |
0.0 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 |
0.4 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.1 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.2 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.0 |
0.0 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.0 |
0.4 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.0 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) |
| 0.0 |
0.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.3 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.2 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.0 |
1.0 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.2 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.6 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.0 |
0.3 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
1.0 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.2 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.0 |
0.1 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.0 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.4 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.3 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.1 |
GO:0090051 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.0 |
0.1 |
GO:1990776 |
S-adenosylmethionine cycle(GO:0033353) angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.0 |
0.4 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of JNK cascade(GO:0046329) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.3 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.3 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.1 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.0 |
0.0 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.0 |
0.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.0 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.2 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.3 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.9 |
GO:0010389 |
regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
| 0.0 |
0.1 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.6 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.1 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 |
0.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.0 |
GO:0071649 |
negative regulation of mitochondrial fusion(GO:0010637) negative regulation of defense response to virus by host(GO:0050689) negative regulation of type I interferon-mediated signaling pathway(GO:0060339) regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.0 |
0.1 |
GO:0045655 |
regulation of monocyte differentiation(GO:0045655) |
| 0.0 |
0.1 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.0 |
0.3 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
0.3 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.3 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.1 |
GO:0050832 |
response to fungus(GO:0009620) defense response to fungus(GO:0050832) |
| 0.0 |
0.3 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 |
0.1 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 |
0.2 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.1 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.7 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.0 |
0.0 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.0 |
0.1 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.0 |
0.3 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.1 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.0 |
0.5 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.1 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 |
0.1 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.0 |
0.0 |
GO:0030323 |
respiratory tube development(GO:0030323) |
| 0.0 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.0 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.2 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) specification of symmetry(GO:0009799) determination of bilateral symmetry(GO:0009855) |
| 0.0 |
0.2 |
GO:0045843 |
negative regulation of striated muscle tissue development(GO:0045843) |
| 0.0 |
0.3 |
GO:0001947 |
heart looping(GO:0001947) |
| 0.0 |
0.1 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.0 |
0.2 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.4 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.2 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.2 |
GO:0072348 |
sulfur compound transport(GO:0072348) |
| 0.0 |
0.7 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
0.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.1 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.0 |
0.1 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.1 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
| 0.0 |
0.1 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.0 |
0.0 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.0 |
0.4 |
GO:2000116 |
regulation of cysteine-type endopeptidase activity(GO:2000116) |
| 0.0 |
0.0 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 |
0.2 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.5 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
0.3 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.1 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.2 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.4 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
